STI 571 teams up to trick CML cells into self-betrayal

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1280, 2001-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STI 571 strengthens its standing in CML

By  

Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

STI-571 active and well tolerated in CML and ALL

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

STI 571 active in patients with rare GI cancer

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 49-57

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 285-299

Bentham Science Publishers

Access to resources Recommend Favorite